Prime Medicine, Inc. (PRME) NASDAQ
3.21
-0.19(-5.59%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 516.19M |
| Enterprise Value | 569.59M |
| P/E Ratio | -2.87 |
| PEG Ratio | -0.1 |
| Price/Sales Ratio | 143.72 |
| Price/Book Ratio | 7.41 |
| Enterprise/Revenue | 156.22 |
| Enterprise/EBITDA | -3.22 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -49.18 |
| Operating Margin | -51.22 |
Management Effectiveness
| Return On Assets | -0.67 |
| Return On Equity | -1.89 |
Income Statement
| Revenue | 4.63M |
| Revenue/Share | 0.02 |
| Gross Profit | -2.69M |
| EBITDA | -195.76M |
| Net Income | -201.14M |
| Diluted EPS | -1.35 |
Balance Sheet
| Total Cash | 135.5M |
| Total Cash/Share | 0.77 |
| Total Debt | 114.51M |
| Total Debt/Equity | 1.49 |
| Current Ratio | 3.8 |
| Book Value Per Share | 0.43 |
Price History
| 52-Week Change | 141.35 |
| 52-Week High | 6.94 |
| 52-Week Low | 1.29 |
| Moving Average 50 Days | 3.41 |
| Moving Average 200 Days | 3.97 |
Statistics
| Average Volume | 2.36M |
| Shares Outstanding | 180.62M |
| % Held by Institutions | 66.1 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
